Добірка наукової літератури з теми "Nalm6 cells"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Nalm6 cells".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Nalm6 cells"
Ramírez Saldaña, Maricela, Miguel Aguilar Santelises, Martha Moreno Lafont, Leopoldo Santos Argumedo, Vladimir Paredes Cervantes, and Rubén López Santiago. "Human B cells are targets for Brucella abortus infection. (P3130)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 186.12. http://dx.doi.org/10.4049/jimmunol.190.supp.186.12.
Повний текст джерелаTang, Yongmin, Lixia Li, Di Wang, Hongqiang Shen, Baiqin Qian, Chunfang Luo, and Haizhong Zhang. "Study on the Preparation of the Immunotoxin 2E8-NCTD and Its Targeting Killing Effect In Vitro." Blood 110, no. 11 (November 16, 2007): 4186. http://dx.doi.org/10.1182/blood.v110.11.4186.4186.
Повний текст джерелаIwasa, Masaki, Yasuo Miura, Aya Fujishiro, Sumie Fujii, Noriko Sugino, Satoshi Yoshioka, Akihiro Tamura, et al. "Bortezomib Attenuates Adhesion of B Cell Precursor Acute Lymphoblastic Lleukemia Cells to Bone Marrow Mesenchymal Stromal/Stem Cells Via Regulating SPARC Expression." Blood 126, no. 23 (December 3, 2015): 786. http://dx.doi.org/10.1182/blood.v126.23.786.786.
Повний текст джерелаHermanova, Ivana, Karel Valis, Karel Fiser, Hana Nuskova, Jan Trka, and Julia Starkova. "L-Asparaginase Strongly Affects Bioenergetics in Leukemic Cells." Blood 120, no. 21 (November 16, 2012): 779. http://dx.doi.org/10.1182/blood.v120.21.779.779.
Повний текст джерелаGu, Yan, Chunhua Song, Sinisa Dovat, Qinglong Guo, Qinyu Ge, and Zheng Ge. "Oncogenesis of CRLF2 Overexpression and Effect of JAK2 Inhibitor in CRLF2 Overexpressed B-Cell Acute Lymphoblastic Leukemia." Blood 134, Supplement_1 (November 13, 2019): 2757. http://dx.doi.org/10.1182/blood-2019-125259.
Повний текст джерелаBarredo, Julio C., Sanja Altman-Hamandzic та Guy J. Leclerc. "Differences in Folylpoly-γ-Glutamate Synthetase (FPGS) Expression in Childhood ALL Result from Cell Lineage of Origin and Presence of Non-Random Translocations." Blood 104, № 11 (16 листопада 2004): 2087. http://dx.doi.org/10.1182/blood.v104.11.2087.2087.
Повний текст джерелаBorges, Christopher M., Kevin Wasko, Jared M. Nasser, Kelly Donahue, Amanda Pfautz, Lincy P. Antony, Glenn Leary, Steven Sexton, Richard A. Morgan, and Karrie K. Wong. "Preclinical Development of Edit-201, a Multigene Edited Healthy Donor NK Cell with Enhanced Anti-Tumor Function and Superior Serial Killing Activity in an Immunosuppressive Environment." Blood 136, Supplement 1 (November 5, 2020): 33. http://dx.doi.org/10.1182/blood-2020-139988.
Повний текст джерелаWang, Lingyan, Yue Zhang, Eden Anderson, Rajesh Kumar, Adam J. Lamble, and Rimas J. Orentas. "CD22 CAR-T Induces Both CD19 and CD22 Surface Down-Modulation: Defining a Mechanism of Generalized Immune Evasion and the Effects of Epigenetic Modifiers." Blood 136, Supplement 1 (November 5, 2020): 22–23. http://dx.doi.org/10.1182/blood-2020-134930.
Повний текст джерелаBarredo, Julio C., Tingting Kinser та Guy J. Leclerc. "TEL/AML1 and E2A/PBX1 Tranlsocations Lead to Altered Folylpoly-γ-Glutamate Synthetase (FPGS) Expression in ALL." Blood 106, № 11 (16 листопада 2005): 539. http://dx.doi.org/10.1182/blood.v106.11.539.539.
Повний текст джерелаTukaramrao, Diwakar Bastihalli, Arati Sharma, Dhimant Desai та Sinisa Dovat. "Abstract 6052: Metabolic consequences of casein kinase 2α inhibition in lymphoid leukemia". Cancer Research 83, № 7_Supplement (4 квітня 2023): 6052. http://dx.doi.org/10.1158/1538-7445.am2023-6052.
Повний текст джерелаДисертації з теми "Nalm6 cells"
Henry, Danielle. "The role of the human INO80 complex in telomere maintenance." Thesis, 2020. http://hdl.handle.net/1866/24728.
Повний текст джерелаThe ends of chromosomes contain telomeric repeats that prevent the DNA damage response from being activated in order to preserve genomic integrity. Telomerase functions to alleviate incomplete DNA replication at telomeres, and to repair those telomeres damaged by various means including oxidative damage. The lifespan of telomerase negative somatic cells is normally restricted by gradual telomere shortening which can lead to the activation of the p53 pathway resulting in cellular growth arrest. Cancer cells often elongate their telomeres in order to acquire cellular immortality predominantly by reactivating telomerase or by using recombination-based, alternative telomere lengthening methods. Previously in our lab, a genome-wide CRISPR screen was conducted in the pre-B cell line NALM-6 treated with a small molecule inhibitor of telomerase, BIBR1532. These previous results suggested that five subunits of the INO80 chromatin-remodeling complex, when independently deleted, reduced cellular proliferation in cells with BIBR1532 induced telomere shortening. My goal was to investigate this genetic interaction in order to understand the biological processes implicated in this synthetic lethal relationship. After the knockout of the genes encoding both the enzymatic subunit of human telomerase (hTERT) and specific subunits of the human INO80 complex, I found that the proliferative capacity of NALM-6 cells was reduced. This result indicates the genetic interaction identified by CRISPR screening is in fact specific. In addition, after p53 stimulation with nutlin-3a treatment, expression levels of the p53 pathway component MDM2 were altered after the knockout of the genes encoding specific subunits of the human INO80 complex, NFRKB and UCHL5, individually. CDKN1A expression was also altered after nutlin-3a treatment and NFRKB knockout. Finally, the loss of telomerase (hTERT) alters the expression levels of the p53 pathway components CDKN1A, BAX and MDM2. In conclusion, the deletion of the genes encoding specific subunits of the INO80 complex, including NFRKB and UCHL5, is harmful to cells after hTERT knockout. The human INO80 complex may be involved in inhibiting the p53 pathway, in response to p53 activation by short telomeres or nutlin-3a treatment. Further investigation into this synthetic lethal relationship may shed light on new combinatorial therapeutics in cancer.
Частини книг з теми "Nalm6 cells"
Adachi, Noritaka, Aya Kurosawa, and Hideki Koyama. "Highly Proficient Gene Targeting by Homologous Recombination in the Human Pre-B Cell Line Nalm-6." In Chromosomal Mutagenesis, 17–29. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-232-8_2.
Повний текст джерелаDrexler, Hans G. "NALM-1." In The Leukemia-Lymphoma Cell Line FactsBook, 115–16. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50041-3.
Повний текст джерелаDrexler, Hans G. "NALM-6." In The Leukemia-Lymphoma Cell Line FactsBook, 117–18. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50042-5.
Повний текст джерелаDrexler, Hans G. "NALM-16." In The Leukemia-Lymphoma Cell Line FactsBook, 119. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50043-7.
Повний текст джерелаDrexler, Hans G. "NALM-19." In The Leukemia-Lymphoma Cell Line FactsBook, 120. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50044-9.
Повний текст джерелаDrexler, Hans G. "NALM-20." In The Leukemia-Lymphoma Cell Line FactsBook, 121–22. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50045-0.
Повний текст джерелаDrexler, Hans G. "NALM-24." In The Leukemia-Lymphoma Cell Line FactsBook, 123–24. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50046-2.
Повний текст джерелаDrexler, Hans G. "NALM-26." In The Leukemia-Lymphoma Cell Line FactsBook, 125. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50047-4.
Повний текст джерелаDrexler, Hans G. "NALM-27." In The Leukemia-Lymphoma Cell Line FactsBook, 126–27. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50048-6.
Повний текст джерелаDrexler, Hans G. "NALM-29." In The Leukemia-Lymphoma Cell Line FactsBook, 128–29. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012221970-2/50049-8.
Повний текст джерелаТези доповідей конференцій з теми "Nalm6 cells"
Lu, Jun Q., Huafeng Ding, Carissa L. Reynolds, Yuanming Feng, Li V. Yang, Fred E. Bertrand, Tom J. McConnell, and Xin-Hua Hu. "Angle-resolved Light Scattering Study of NALM-6 and HL-60 Cells for White Blood Cell Differentiation." In Biomedical Optics. Washington, D.C.: OSA, 2010. http://dx.doi.org/10.1364/biomed.2010.btud85.
Повний текст джерела